'Vaping': The BfR advises against self-mixing e-liquids

November 06, 2019

This is pointed out by the German Federal Institute for Risk Assessment (BfR) following the frequent occurrences of severe lung disorders amongst "vapers" in the USA. "According to current understanding, e-cigarette consumers in Germany do not face any increased risks, provided they continue to use products that comply with European and German regulations," says BfR President Professor Dr. Dr. Andreas Hensel. "However, 'vapers' should pay attention to symptoms such as breathing difficulties or chest pain, especially after product change."

E-cigarettes heat up a liquid (usually containing nicotine) until it has vaporised, so that it can be inhaled. According to current knowledge, e-cigarettes are less harmful than conventional tobacco products when used as intended. However, insufficiently studied ingredients and impurities as well as new liquid and vaporisation products, may increase health risks. In addition, high-power "sub ohm" models allow large quantities of vapour straight into the lungs. The effects of this are yet to be fully studied. Nicotine-free liquids may also be problematic. They do not come under the tobacco regulation and therefore do not need to comply with provisions for products that contain nicotine, such as prohibitions on the use of ingredients that may pose a risk to health as well as applicable reporting requirements. DIY e-liquids are often the cause of calls and enquiries to toxicology information centres.

In the USA, a series of severe lung disorders with associated shortness of breath, coughing, and chest pain were reported within a very short period. Symptoms such as nausea, vomiting, diarrhoea, and abdominal pain have been reported, also cases of deaths have occurred. According to a study by the "New England Journal of Medicine", the affected vapers were 19 years old on average. In the majority of cases, they used cannabis products (Tetrahydrocannabinol) that did not originate from normal retail sources. Which substance or factors led to the lung disease is still unclear.

Due to the fact that these problems occurred within a short period of time and affected young people in particular, the BfR has concluded that the problem is rather an acute one. A detailed clarification of the causes of the events in the USA is necessary before further recommendations can be made.
About the BfR

The German Federal Institute for Risk Assessment (BfR) is a scientifically independent institution within the portfolio of the Federal Ministry of Food and Agriculture (BMEL). It advises the Federal Government and Federal Laender on questions of food, chemical and product safety. The BfR conducts its own research on topics that are closely linked to its assessment tasks.

This text version is a translation of the original German text which is the only legally binding version.

BfR Federal Institute for Risk Assessment

Related Chest Pain Articles from Brightsurf:

New approach helps EMTs better assess chest pain en route to hospital
A study conducted at Wake Forest Baptist Health shows that on-scene use of a new protocol and advanced diagnostic equipment can help paramedics better identify patients at high risk for adverse cardiac events.

Brain activity during psychological stress may predict chest pain in people with heart disease
The brain's reaction to stress could be an important indicator of angina (chest pain) among people with known heart disease.

Chest pain, stress tests warrant attention even if arteries are clear
Patients who experience chest pain and have abnormal results on a cardiac stress test but who do not have blocked arteries often experience changes in their symptoms and stress test results over time, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).

Women carry heavier burden of chest pain, but less artery narrowing
Women with coronary artery disease that reduces blood flow and oxygen to the heart muscle (ischemia) have significantly more chest pain caused by plaque build-up, yet less extensive disease as compared with men, according to new research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).

More isn't better when it comes to evaluating chest pain
New and more effective tests are needed to help predict heart attacks and other major cardiac events in patients with chest pain, the second most common reason for emergency department visits in the US.

Artificial intelligence could prevent unneeded tests in patients with stable chest pain
Artificial intelligence (AI) could prevent unnecessary diagnostic tests in patients with stable chest pain, according to research presented today at ICNC 2019.

Kaiser Permanente improves emergency care for patients with chest pain
Emergency physicians at Kaiser Permanente hospitals in Southern California reduced hospital admissions and cardiac stress testing by using new criteria to assess the level of risk patients with chest pain have for subsequent cardiac events.

Treatment for underdiagnosed cause of debilitating chest pain
Researchers find an effective way to treat an underdiagnosed condition that can cause heart attack and heart-attack-like symptoms.

Diagnostic protocol effective in identifying ED patients with acute chest pain
A relatively new accelerated diagnostic protocol is effective in identifying emergency department patients with acute chest pain who can be safely sent home without being hospitalized or undergoing comprehensive cardiac testing, according to researchers at Wake Forest Baptist Medical Center.

Chest pain drug falls short in preventing first episode of ventricular arrhythmia or death
A trial of more than 1,000 patients with implantable cardioverter defibrillators found that the drug ranolazine (used to treat chest pain; brand name Ranexa®) was safe but didn't decrease the likelihood of the first occurrence of ventricular arrhythmias or death in this high-risk population.

Read More: Chest Pain News and Chest Pain Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.